CYP2C19 is a cytochrome P450 enzyme primarily involved in drug metabolism (e.g., clopidogrel, proton pump inhibitors). Its direct utility for fertility is not supported by strong evidence. Some mechanistic studies suggest CYP2C19 variants might influence estrogen metabolism or response to fertility drugs, but findings are inconsistent and lack replication. Current evidence is best described as unclear or mixed. Therefore, a CYP2C19 genetic test is not a validated tool for fertility assessment. More established factors include age, hormone levels, lifestyle, and other genetic markers like MTHFR. Caveat: Without robust clinical trials, any claimed link remains speculative. Do not base reproductive decisions solely on such tests.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-4a38a0240c34315fe737ec8a